Regulatory Filings • Jun 14, 2023
Regulatory Filings
Open in ViewerOpens in native device viewer
The Board of Directors of Medinice S.A. (the _quot;Company_quot;) announces thaton 13 June the Company received from the Canadian Patent Office,confirmation of patent protection for the invention entitled _quot;COOLCRYO_#174;_quot;.
CoolCryo_#174; is a system for performing minimally invasive cardiaccryoablation. CoolCryo_#174; uses liquid nitrogen to obtain very lowtemperatures for tissue destruction. The system has been designedspecifically for cardiac ablation, which is ultimately to be performedusing minimally invasive videothoracoscopic techniques, a majorcompetitive advantage.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.